MDMA

3,4-Methylenedioxymethamphetamine

EcstasyMollyXEXTCMandyMDPillsBeansRolls
Open Interactive Guide →

MDMA is an empathogen-entactogen that produces intense feelings of emotional closeness, euphoria, enhanced tactile sensation, and increased empathy. Used in sexual contexts for emotional connection and heightened physical sensitivity. Often sold as pressed pills ('ecstasy') or crystals/powder ('molly').

How It Works

MDMA primarily triggers massive serotonin release (and to a lesser extent, dopamine and norepinephrine) by reversing the serotonin transporter. Also triggers release of oxytocin, contributing to feelings of bonding and trust.

Legal Status

Schedule I in US. Class A in UK. Illegal in most countries. Breakthrough Therapy designation from FDA for PTSD treatment (as of 2023).

Dosage Guide (Oral)

LevelAmount (mg)
Threshold30mg
Light40-75mg
Common75-125mg
Strong125-175mg
Heavy175mg+ (significantly increased neurotoxicity)

Note: Rule of thumb: 1.5mg/kg body weight as a reasonable dose. Pressed pills vary wildly in content (50-300mg+) and may contain other substances. ALWAYS test with reagent kits. Redosing should be half the initial dose at most, and only once.

Organ System Impacts

cardiovascular — Moderate
Increased heart rate and blood pressure. Generally manageable in healthy individuals at normal doses. Risk increases significantly with exertion, heat, and dehydration. MDMA-related cardiovascular complications include arrhythmias and myocardial stress.
neurological — High
Massive serotonin release followed by depletion. Neurotoxic to serotonin neurons with repeated or heavy use. Chronic use causes memory problems, depression, anxiety, sleep disorders. Spacing use by 6-12 weeks is critical to allow serotonin system recovery.
ocular — Low
Dilated pupils. Nystagmus at higher doses. Blurred vision. Increased light sensitivity. Effects resolve within hours of use offset.
dermatological — Low
Flushing and profuse sweating from temperature dysregulation, especially in hot/dancing environments. No direct skin toxicity. Sweating-related dehydration risk in prolonged use.
respiratory — Low
Minimal direct respiratory effects. MDMA is not a respiratory depressant. Increased respiratory rate may occur from sympathomimetic effects, but no clinically significant respiratory toxicity.
hepatic — Moderate
MDMA is hepatotoxic. Most cases show mild transaminase elevation, but rare fulminant liver failure cases are documented. Risk increases substantially with high doses and repeated use. Alcohol co-use increases hepatotoxicity risk.
hematological — Low
MDMA causes serotonin-related platelet effects. Hyponatremia (low blood sodium) can occur from SIADH (syndrome of inappropriate antidiuretic hormone secretion) combined with excessive water intake. Careful fluid management is critical. Possible effect on immune function with repeated use.
renal — Moderate
MDMA causes antidiuretic hormone release (SIADH), promoting water retention. Combined with excessive water intake, this causes hyponatremia (water intoxication), which can be fatal. Conversely, dehydration from dancing and heat is an opposite risk. Careful fluid balance essential.
gastrointestinal — Low
Nausea on come-up is common, especially with oral route. Loss of appetite. Generally mild GI effects that resolve within hours. No significant GI toxicity at acute doses.
musculoskeletal — Low
Bruxism (jaw clenching, teeth grinding) is very common and can cause TMJ pain and dental wear. Muscle tension. Generally not dangerous but uncomfortable. Magnesium supplementation may help reduce symptoms.

Effects

Desired Effects

Negative Effects

Rare but Serious

Drug Interactions

MAOIs (certain antidepressants) — deadly

MAOIs prevent serotonin breakdown. MDMA floods serotonin. Result: life-threatening serotonin syndrome.

Action: Absolute contraindication. Wait at least 2 weeks after stopping MAOIs before MDMA.

Methamphetamine — dangerous

Both release serotonin and increase stimulation. Additive neurotoxicity, cardiovascular strain, and hyperthermia risk.

Action: Avoid combination.

SSRIs / SNRIs (Prozac, Zoloft, Lexapro, etc.) — moderate

SSRIs block the serotonin transporter that MDMA uses. Effects: MDMA is weakened or blocked. Serotonin syndrome risk is lower than with MAOIs but still possible.

Action: MDMA will mostly not work on SSRIs. Do NOT take extra MDMA to compensate — this increases neurotoxicity without proportionally increasing effects.

Alcohol — moderate

MDMA masks alcohol intoxication. Increased dehydration and liver burden.

Action: If drinking, keep it minimal. Prioritize water.

Detection Times

MDMA can trigger positive results on amphetamine immunoassays and has its own confirmatory tests.

Urine

Detected on standard amphetamine panel or specific MDMA test. Detection window: up to 4 days.

Blood

Short blood detection window. Detection window: up to 2 days.

Hair

Hair follicle test detects use over months. Detection window: up to 90 days.

Saliva

Oral fluid test for recent use. Detection window: up to 2 days.

Harm Reduction Tips

Withdrawal Symptoms

Severity: Low

Comedown: 1-3 days after use. Serotonin recovery: 2-4 weeks with moderate use. Heavy/frequent users: full neurochemical recovery may take months.

Physical

Psychological

Emergency Information

Call 911 If:

What To Do

  1. Move to a cool area immediately
  2. Remove excess clothing
  3. Apply cool water to skin (armpits, neck, groin)
  4. Sip (don't chug) cool water or electrolyte drinks
  5. If person is overheating: this is a medical emergency — call 911
  6. If serotonin syndrome suspected: stop all serotonergic substances, cool patient, call 911

What To Tell EMS

The patient took MDMA (ecstasy/molly). Report dose, time of ingestion, other substances. Key concerns: hyperthermia, serotonin syndrome, hyponatremia. Cooling measures are first priority. Dantrolene for severe hyperthermia. Cyproheptadine for serotonin syndrome.

Seek Help If

Normal Discomfort

Harm reduction information only. This is not medical advice. If you are experiencing a medical emergency, call 911 immediately.